HemoCath is dedicated to optimizing the management of acute heart failure through innovative monitoring solutions
HemoCath is dedicated to optimizing the management of acute heart failure through innovative monitoring solutions
HemoCath Medical Ltd. is an Irish–US MedTech and Digital Health company transforming the management of acute heart failure with the HemoDynamix™ AI Platform — a scalable, next-generation solution for diagnosis, treatment, and monitoring.
The platform combines the HemoCath™ pulmonary artery catheter with cloud-based AI to deliver real-time, data-driven insights that guide clinical decisions — for better health failure care management — improving patient outcomes, and reducing hospital costs.
Our leadership team brings over 150 years of combined experience in medicine, engineering, commercialization, and corporate finance — with a proven record of turning breakthrough innovations into market successes.
We are committed to revolutionizing acute heart failure management by providing clinicians with accurate, continuous data-driven insights necessary for immediate, life-saving decisions.